Patten Group’s Biogen BIIB Stock Holding History

Patten Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-482	Closed	-$145K	–	228
2018 Q4	$145K	Buy	482 +10	+2%	+$3.19K	0.07%	192
2018 Q3	$167K	Hold	472	–	–	0.06%	205
2018 Q2	$137K	Hold	472	–	–	0.05%	216
2018 Q1	$129K	Hold	472	–	–	0.05%	219
2017 Q4	$150K	Buy	472 +10	+2%	+$3.21K	0.06%	214
2017 Q3	$145K	Hold	462	–	–	0.06%	220
2017 Q2	$133K	Sell	462 -43	-9%	-$11.4K	0.05%	230
2017 Q1	$136K	Hold	505	–	–	0.06%	215
2016 Q4	$140K	Sell	505 -30	-6%	-$8.89K	0.06%	210
2016 Q3	$157K	Sell	535 -15	-3%	-$4.44K	0.07%	193
2016 Q2	$133K	Sell	550 -40	-7%	-$10.5K	0.06%	211
2016 Q1	$154K	Hold	590	–	–	0.07%	188
2015 Q4	$181K	Sell	590 -103	-15%	-$29.6K	0.09%	168
2015 Q3	$202K	Hold	693	–	–	0.1%	162
2015 Q2	$280K	Hold	693	–	–	0.13%	146
2015 Q1	$293K	Sell	693 -45	-6%	-$17.7K	0.15%	142
2014 Q4	$250K	Buy	+738	New	+$239K	0.12%	154

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Patten Group's BIIB Position: Q1 2019 in Review

Patten Group sold out of Biogen (BIIB) in Q1 2019, closing a stake of 482 shares — an estimated $145K sold.

Patten Group first reported a position in BIIB in Q4 2014 and held it in 17 quarters. The position peaked at $293K in Q1 2015. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Patten Group reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Patten Group sold 482 Biogen shares in Q1 2019, an estimated $145K.
Patten Group first reported a position in Biogen in Q4 2014 and held it in 17 quarters.
Patten Group's Biogen position peaked at $293K in Q1 2015.
1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Patten Group's 13F filing for Q1 2019, filed 14 May 2019.